Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Three Gene Signature for Predicting the Development of Hepatocellular Carcinoma in Chronically Infected Hepatitis C Virus Patients.
Ibrahim MK, Salama H, Abd El Rahman M, Dawood RM, Bader El Din NG, Salem HF, Abdelrahim ME, Omran D, Omran MH, El-Wakeel KH, Abdelhafez TH, Khedr A, El Awady MK. Ibrahim MK, et al. Among authors: omran mh, omran d. J Interferon Cytokine Res. 2016 Dec;36(12):698-705. doi: 10.1089/jir.2016.0042. Epub 2016 Oct 11. J Interferon Cytokine Res. 2016. PMID: 27726464
Determinants of Infection Outcome in HCV-Genotype 4.
Zayed RA, Omran D, Zayed AA, Elmessery LO. Zayed RA, et al. Among authors: omran d. Viral Immunol. 2017 Oct;30(8):560-567. doi: 10.1089/vim.2017.0071. Epub 2017 Jul 21. Viral Immunol. 2017. PMID: 28731371 Review.
Spur-of-the-Moment Modification in National Treatment Policies Leads to a Surprising HCV Viral Suppression in All Treated Patients: Real-Life Egyptian Experience.
El Kassas M, Omran D, Elsaeed K, Alboraie M, Elakel W, El Tahan A, Abd El Latif Y, Nabeel MM, Korany M, Ezzat S, El-Serafy M, ElShazly Y, Doss W, Esmat G. El Kassas M, et al. Among authors: omran d. J Interferon Cytokine Res. 2018 Feb;38(2):81-85. doi: 10.1089/jir.2017.0121. Epub 2018 Jan 22. J Interferon Cytokine Res. 2018. PMID: 29356573
Safety and efficacy of sofosbuvir/ledipasvir and sofosbuvir/daclatasvir in the treatment of hepatitis C in patients with decompensated cirrhosis.
El Kassas M, Abdeen N, Omran D, Alboraie M, Salaheldin M, Eltabbakh M, Farghaly R, Emadeldeen M, Afify S, Sweedy A, Ghalwash A, Abbass A, Ezzat S, Tahoon M, ELshazly HM, Hamdy H, Omar H. El Kassas M, et al. Among authors: omran d. Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e877-e882. doi: 10.1097/MEG.0000000000002287. Eur J Gastroenterol Hepatol. 2021. PMID: 34560693
92 results